Related Experiment Video
Updated: Apr 27, 2026
12:12
Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
12.9K
Glucolipotoxicity in Pancreatic β-Cells
1Department of Endocrinology and Metabolism, Convergent Research Consortium for Immunologic Disease, The Catholic University of Korea, Seoul, Korea.
Diabetes & Metabolism Journal
|November 24, 2011
Summary
Asian type 2 diabetes involves earlier onset and lower BMI, suggesting insulin defects are key. Glucolipotoxicity, caused by high glucose and free fatty acids, damages beta cells, offering new treatment targets.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Research
Background:
- Type 2 diabetes epidemic in Asia presents unique characteristics: rapid onset, earlier age, and lower body mass index (BMI).
- These features suggest a significant role for insulin secretory defects in Asian diabetes development and progression.
- Beta-cell (β-cell) dysfunction and reduced β-cell mass are influenced by genetics and modifiable factors like chronic hyperglycemia and elevated free fatty acids (FFAs).
Purpose of the Study:
- To investigate the phenomenon of "glucolipotoxicity" in the context of Asian type 2 diabetes.
- To explore the mechanisms underlying glucolipotoxicity-induced β-cell dysfunction and death.
- To identify potential new therapeutic strategies for type 2 diabetes mellitus.
Main Methods:
- The study reviews existing literature and proposes mechanisms for glucolipotoxicity.
- It focuses on the impact of combined glucose and FFA toxicity on β-cells.
- Analysis of intracellular energy metabolism and oxidative stress in β-cell dysfunction.
Main Results:
- Neither glucose nor FFAs alone cause significant β-cell toxicity in individuals with normal or impaired glucose tolerance.
- "Glucolipotoxicity" is proposed as a more accurate term for the combined effect.
- Key factors in glucolipotoxicity include suppressed transcription factor gene expression due to altered intracellular metabolism and oxidative stress.
Conclusions:
- Glucolipotoxicity plays a critical role in β-cell dysfunction and death, particularly in the context of Asian type 2 diabetes.
- Stabilizing metabolic changes induced by glucolipotoxicity in β-cells presents a novel therapeutic approach.
- Targeting glucolipotoxicity mechanisms could lead to effective treatments for type 2 diabetes mellitus.
Related Concept Videos
01:05Insulin Secretory Vesicles
6.2K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.2K
01:16Hormones Regulating Blood Glucose
7.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.4K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.8K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.8K
01:12Type I Diabetes I: Introduction
40
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
40
01:26Type I Diabetes II: Pathophysiology
57
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
57
01:24Type II Diabetes II: Pathophysiology
19
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
19